| Dr Bonnie Anne Korytkowski, DO | |
|
W3124 Van Roy Rd, Appleton, WI 54915-3929 | |
| (920) 730-2747 | |
| Not Available |
| Full Name | Dr Bonnie Anne Korytkowski |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | W3124 Van Roy Rd, Appleton, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093211211 | NPI | - | NPPES |
| K400769234 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 72653-21 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Thedacare Regional Medical Center - Appleton Inc | Appleton, WI | Hospital |
| Ascension Ne Wisconsin - St Elizabeth Campus | Appleton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Care Of The Fox Cities Sc | 4486664174 | 4 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.
Researchers at Princeton have developed a dual catalyst system that directly installs alkyl groups-fragments containing singly bonded carbon and hydrogen atoms that have extremely useful properties for drug discovery-onto compounds called heteroarenes. The new reaction uses simple and abundant alcohols and offers a milder and more widely applicable alternative to existing strategies.
New diagnostic criteria were introduced this week for neuromyelitis optica, now called neuromyelitis optica spectrum disorder, which is an inflammatory disease of the central nervous system that is sometimes mistaken for multiple sclerosis.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed U.S. neurologists selected Biogen Idec/Elan's Tysabri as the most effective therapy for the treatment of relapsing-remitting multiple sclerosis, when compared to other currently available agents.
› Verified 1 days ago
| Entity Name | Family Care Of The Fox Cities Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841346749 PECOS PAC ID: 4486664174 Enrollment ID: O20060425000795 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.
Researchers at Princeton have developed a dual catalyst system that directly installs alkyl groups-fragments containing singly bonded carbon and hydrogen atoms that have extremely useful properties for drug discovery-onto compounds called heteroarenes. The new reaction uses simple and abundant alcohols and offers a milder and more widely applicable alternative to existing strategies.
New diagnostic criteria were introduced this week for neuromyelitis optica, now called neuromyelitis optica spectrum disorder, which is an inflammatory disease of the central nervous system that is sometimes mistaken for multiple sclerosis.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed U.S. neurologists selected Biogen Idec/Elan's Tysabri as the most effective therapy for the treatment of relapsing-remitting multiple sclerosis, when compared to other currently available agents.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bonnie Anne Korytkowski, DO W3124 Van Roy Rd, Appleton, WI 54915-3929 Ph: () - | Dr Bonnie Anne Korytkowski, DO W3124 Van Roy Rd, Appleton, WI 54915-3929 Ph: (920) 730-2747 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.
Researchers at Princeton have developed a dual catalyst system that directly installs alkyl groups-fragments containing singly bonded carbon and hydrogen atoms that have extremely useful properties for drug discovery-onto compounds called heteroarenes. The new reaction uses simple and abundant alcohols and offers a milder and more widely applicable alternative to existing strategies.
New diagnostic criteria were introduced this week for neuromyelitis optica, now called neuromyelitis optica spectrum disorder, which is an inflammatory disease of the central nervous system that is sometimes mistaken for multiple sclerosis.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed U.S. neurologists selected Biogen Idec/Elan's Tysabri as the most effective therapy for the treatment of relapsing-remitting multiple sclerosis, when compared to other currently available agents.
› Verified 1 days ago
Michael John Van Abel, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 | |
Stephen C Fuller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 | |
Samuel James Heiks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 Fax: 920-996-1054 | |
Brittany E Goodrich-braun, Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 3925 N Gateway Dr, Appleton, WI 54913 Phone: 920-830-6877 | |
Dirk Jon Derksen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Wagon Wheel Dr, Appleton, WI 54913 Phone: 920-731-6374 | |
Ms. Cynthia Frances Susedik, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3925 N Gateway Dr, Appleton, WI 54913 Phone: 920-830-6877 Fax: 920-993-5037 | |
N Carter Noble, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3329 N Richmond St, Appleton, WI 54911 Phone: 920-380-2715 |